Inhibition Of Wee1 Enhances The Anti-Leukemic Effects Of Antimetabolites In Vitro and In Vivo

被引：1
作者：
Ford, James B.
Fosmire, Susan
van Linden, Annemie
Baturin, Dmitry
Porter, Christopher C.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1281.1281
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1281
引用
收藏
页数：2
相关论文
共 50 条
[41]   Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo [J].
Fangbing Liu ;
Tristan Knight ;
Yongwei Su ;
Holly Edwards ;
Guan Wang ;
Yue Wang ;
Jeffrey W. Taub ;
Hai Lin ;
Liwei Sun ;
Yubin Ge .
Targeted Oncology, 2019, 14 :351-364
[42]   In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors [J].
Myers, DE ;
ChandanLanglie, M ;
Chelstrom, LM ;
Uckun, FM .
LEUKEMIA & LYMPHOMA, 1996, 22 (3-4) :259-264
[43]   Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo [J].
Liu, Fangbing ;
Knight, Tristan ;
Su, Yongwei ;
Edwards, Holly ;
Wang, Guan ;
Wang, Yue ;
Taub, Jeffrey W. ;
Lin, Hai ;
Sun, Liwei ;
Ge, Yubin .
TARGETED ONCOLOGY, 2019, 14 (03) :351-364
[44]   In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia [J].
Strese, Sara ;
Hassan, Saadia Bashir ;
Velander, Ebba ;
Haglund, Caroline ;
Hoglund, Martin ;
Larsson, Rolf ;
Gullbo, Joachim .
ONCOTARGET, 2017, 8 (04) :6341-6352
[45]   Relevance of substrate selection for the results of biochemical WEE1 in-vitro kinase activity inhibition assays [J].
Mueller, Daniel G. ;
Gericke, Andreas ;
Totzke, Frank ;
Heidemann-Dinger, Carolin ;
Ketterer, Constance ;
Kraemer, Diane ;
Weber, Thomas ;
Kubbutat, Michael H. .
CANCER RESEARCH, 2024, 84 (06)
[46]   Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer [J].
Lee, Yoo-Young ;
Cho, Young-Jae ;
Shin, Sung-won ;
Choi, Changhoon ;
Ryu, Ji-Yoon ;
Jeon, Hye-Kyung ;
Choi, Jung-Joo ;
Hwang, Jae Ryoung ;
Choi, Chel Hun ;
Kim, Tae-Joong ;
Kim, Byoung-Gie ;
Bae, Duk-Soo ;
Park, Won ;
Lee, Jeong-Won .
SCIENTIFIC REPORTS, 2019, 9 (1)
[47]   Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation [J].
Davies, Kurtis D. ;
Cable, P. LouAnn ;
Garrus, Jennifer E. ;
Sullivan, Francis X. ;
von Carlowitz, Ira ;
Le Huerou, Yvan ;
Wallace, Eli ;
Woessner, Richard D. ;
Gross, Stefan .
CANCER BIOLOGY & THERAPY, 2011, 12 (09) :788-796
[48]   Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition [J].
Anne M. van Harten ;
D. Vicky de Boer ;
Sanne R. Martens-de Kemp ;
Marijke Buijze ;
Sonja H. Ganzevles ;
Keith D. Hunter ;
C. René Leemans ;
Victor W. van Beusechem ;
Rob M. F. Wolthuis ;
Renée X. de Menezes ;
Ruud H. Brakenhoff .
Scientific Reports, 10
[49]   Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition [J].
van Harten, Anne M. ;
de Boer, D. Vicky ;
Martens-de Kemp, Sanne R. ;
Buijze, Marijke ;
Ganzevles, Sonja H. ;
Hunter, Keith D. ;
Leemans, C. Rene ;
van Beusechem, Victor W. ;
Wolthuis, Rob M. F. ;
de Menezes, Renee X. ;
Brakenhoff, Ruud H. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[50]   Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1 [J].
Wang, Weirong ;
Zhang, Jianfeng ;
Li, Yanxiang ;
Yang, Xiaofeng ;
He, Yanhao ;
Li, Tingting ;
Ren, Feng ;
Zhang, Jiye ;
Lin, Rong .
CANCER LETTERS, 2015, 356 (02) :791-799
12345